Search Results - Gabriela Alperovich

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Mammalian Target of Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney Disease in Rats

    Mammalian Target of Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney Disease in Rats by Núria Lloberas, Josep M. Cruzado, Marcella Franquesa, I. Herrero, Joan Torrás, Gabriela Alperovich, Inés Rama, August Vidal, Josep M. Grinyó

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Regression of Advanced Diabetic Nephropathy by Hepatocyte Growth Factor Gene Therapy in Rats

    Regression of Advanced Diabetic Nephropathy by Hepatocyte Growth Factor Gene Therapy in Rats by Josep M. Cruzado, Núria Lloberas, Joan Torrás, Marta Riera, Cristina Fillat, I. Herrero, Josep M. Aran, Gabriela Alperovich, August Vidal, Josep M. Grinyó

    Published 2004
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Long‐term efficacy and safety of risankizumab for the treatment of moderate‐to‐severe plaque psoriasis: interim analysis of the LIMMitless open‐label extension trial beyond 3 years of follow‐up

    Long‐term efficacy and safety of risankizumab for the treatment of moderate‐to‐severe plaque psoriasis: interim analysis of the LIMMitless open‐label extension trial beyond 3 years... by Kim Papp, Mark Lebwohl, L. Puig, Mamitaro Ohtsuki, Stefan Beissert, J. Zeng, Simone Rubant, Ranjeeta Sinvhal, Yiwei Zhao, Ahmed M. Soliman, Gabriela Alperovich, C. Leonardi

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Long-term graft function changes in kidney transplant recipients

    Long-term graft function changes in kidney transplant recipients by R Marcén, J. M. Morales, Ana Fernández-Rodríguez, Lluís Capdevila, Luis Pallardó, Juan José González Plaza, Juan José Cubero, Josep Puig, Ana Sánchez‐Fructuoso, M. Arias, Gabriela Alperovich, D. Seron

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial

    Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial by Andrew J.K. Östör, Filip Van den Bosch, Kim Papp, Cecilia Asnal, Ricardo Blanco, Jacob Aelion, Gabriela Alperovich, Wenjing Lü, Zailong Wang, Ahmed M. Soliman, Ann Eldred, Lisa Barcomb, Alan Kivitz

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension

    Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension by Smeeta Sinha, Sagar U. Nigwekar, Vincent Brandenburg, Lisa J. Gould, Thomas E. Serena, Sharon M. Moe, George R. Aronoff, Dinesh K. Chatoth, Jeffrey L. Hymes, Kevin J. Carroll, Gabriela Alperovich, L Keller, Joan Perelló, Alex Gold, Glenn M. Chertow

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    A Qualitative Research for Defining Meaningful Attributes for the Treatment of Inflammatory Bowel Disease from the Patient Perspective

    A Qualitative Research for Defining Meaningful Attributes for the Treatment of Inflammatory Bowel Disease from the Patient Perspective by Édouard Louis, Juan Manuel Ramos-Goñi, Jesús Cuervo, Uri Kopylov, Manuel Barreiro‐de Acosta, Sara McCartney, Greg Rosenfeld, Dominik Bettenworth, Ailsa Hart, Kerri L. Novak, Xavier Donnet, David Easton, Roberto Saldaña, Katja Protze, Eyal Tzur, Gabriela Alperovich, Francesc Casellas

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: